William Blair Issues Negative Estimate for AbbVie Earnings

AbbVie Inc. (NYSE:ABBV – Free Report) – Equities research analysts at William Blair reduced their Q2 2025 earnings per share (EPS) estimates for shares of AbbVie in a report issued on Monday, July 14th. William Blair analyst M. Phipps now forecasts that the company will post earnings per share of $2.88 for the quarter, down […]

Leave a Reply

Your email address will not be published.

Previous post Maple Leaf Foods (TSE:MFI) Price Target Raised to C$41.00
Next post WPM Q2 EPS Forecast Lifted by Raymond James Financial